Last updated: November 9, 2024
Sponsor: Carol Davila University of Medicine and Pharmacy
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Xilocaine Spray Arm
Strepsils Intensiv plus Xilocaine spray Arm
Strepsils Intensiv Arm
Clinical Study ID
NCT06220175
PHRASE
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient with indication of upper gastrointestinal endoscopy with topical pharyngealanesthesia with xilocaine spray
Age above 18 years
Informed consent
Exclusion
Exclusion Criteria:
Allergy to xilocaine and/or flurbiprofen
Absence of informed consent
Study Design
Total Participants: 37
Treatment Group(s): 3
Primary Treatment: Xilocaine Spray Arm
Phase:
Study Start date:
March 01, 2024
Estimated Completion Date:
August 31, 2024
Study Description
Connect with a study center
"Agrippa Ionescu" Hospital
Bucharest,
RomaniaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.